Enjoy complimentary customisation on priority with our Enterprise License!
The bioprocess validation market size is forecast to increase by USD 364 million, at a CAGR of 12.88% between 2023 and 2028. The growth of the market depends on several factors, including increasing demand for biopharmaceuticals, increasing need for quality control in pharmaceutical and biotechnology industries, and rising demand for personalized medicine. Factors such as high costs associated with bioprocess validation, the need for highly trained personnel for conducting bioprocess validation, and the lack of standardized protocols and guidelines for bioprocess validation will hamper the growth of the market. Nevertheless, the increasing adoption of single-use bioprocessing systems, the rising number of drug approvals, and increasing investments in biopharmaceutical manufacturing facilities will drive the growth of the market.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.